LMAT
NASDAQ · Health Care
Lemaitre Vascular Inc
$101.32
-0.87 (-0.85%)
Financial Highlights (FY 2026)
Revenue
195.09M
Net Income
45.12M
Gross Margin
71.5%
Profit Margin
23.1%
Rev Growth
+15.6%
D/E Ratio
0.43
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 71.5% | 71.5% | 55.1% | 55.1% |
| Operating Margin | 27.2% | 24.5% | 15.7% | 15.2% |
| Profit Margin | 23.1% | 22.0% | 12.7% | 14.6% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 195.09M | 168.81M | 688.78M | 823.96M |
| Gross Profit | 139.55M | 120.75M | 379.66M | 454.17M |
| Operating Income | 53.08M | 41.34M | 108.14M | 124.98M |
| Net Income | 45.12M | 35.14M | 87.65M | 120.31M |
| Gross Margin | 71.5% | 71.5% | 55.1% | 55.1% |
| Operating Margin | 27.2% | 24.5% | 15.7% | 15.2% |
| Profit Margin | 23.1% | 22.0% | 12.7% | 14.6% |
| Rev Growth | +15.6% | +15.6% | +17.5% | -8.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 272.39M | 272.39M | 832.61M | 742.63M |
| Total Equity | 635.52M | 635.52M | 1.10B | 1.03B |
| D/E Ratio | 0.43 | 0.43 | 0.76 | 0.72 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 57.49M | 47.26M | 151.37M | 185.12M |
| Free Cash Flow | — | — | 80.37M | 83.71M |